Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN's POC demand, new products and international growth support its outlook, while U.S. channel shifts and distributor timing pose risks.
INGN - Inogen, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$26.00
DETAILS
HIGH:
$26.00
LOW:
$26.00
MEDIAN:
$26.00
CONSENSUS:
$26.00
UPSIDE:
371.87%
Stock News
Dimensional Fund Advisors LP Reduces Position in Inogen, Inc $INGN
Dimensional Fund Advisors LP decreased its holdings in Inogen, Inc (NASDAQ: INGN) by 28.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 509,822 shares of the medical technology company's stock after selling 201,558 shares during the period. Dimensional Fund
Should Investors Buy Inogen as Low Valuation Meets Execution Risk?
Inogen's steep sales-multiple discount, improving margins and firm international demand clash with U.S. sales and rental weakness.
Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists
INGN cuts its 2026 revenue outlook as U.S. channel pressure weighs, while international growth, new products and cost control offer support.
Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut
INGN's Q2 revenues rise 3% as international sales climb 14.8%, but U.S. weakness led it to cut its 2026 revenue outlook.
Inogen, Inc. (INGN) Q2 2026 Earnings Call Transcript
Inogen, Inc. (INGN) Q2 2026 Earnings Call Transcript
Inogen Q2 Earnings Call Highlights
Inogen NASDAQ: INGN reported second-quarter 2026 revenue of $95.1 million, up 3% from a year earlier, as international growth, portable oxygen concentrator demand and contributions from newer products offset continued pressure in its U.S. direct-to-consumer business.
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates
Inogen (INGN) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.15 per share a year ago.
Inogen Announces Second Quarter 2026 Financial Results
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Reported second quarter revenue of $95.1 million. Company raises full-year adjusted EBITDA guidance to approximately $4.0 million.
Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026.
Inogen Announces the Appointment of Andy Reding as Chief Operating Officer
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces the Appointment of Andy Reding as Chief Operating Officer.
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN's POC strength, expanding respiratory portfolio and international momentum support growth, though U.S. revenue pressure remains a key risk.
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN broadens beyond portable oxygen concentrators into home respiratory care, but U.S. revenues face pressure from channel shifts.
Inogen, Inc. (INGN) Q1 2026 Earnings Call Transcript
Inogen, Inc. (INGN) Q1 2026 Earnings Call Transcript
INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves
Inogen posts higher Q1 revenues and improved gross margin as international portable oxygen demand offsets weaker U.S. sales.
Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates
Inogen (INGN) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to a loss of $0.25 per share a year ago.
Inogen Announces First Quarter 2026 Financial Results
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces First Quarter 2026 Financial Results.
Inogen (NASDAQ:INGN) Stock Price Passes Above 50 Day Moving Average – Here’s What Happened
Inogen, Inc (NASDAQ: INGN - Get Free Report) shares crossed above its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $6.29 and traded as high as $7.38. Inogen shares last traded at $6.99, with a volume of 201,150 shares traded. Analyst Ratings Changes Separately, Freedom Capital
Inogen to Report First Quarter 2026 Financial Results on May 7, 2026
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen to Report First Quarter 2026 Financial Results on May 7, 2026.
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN rides surging POC demand and global growth tailwinds, but U.S. channel shifts and macro risks may weigh on near-term performance.